Omar Mohammed Abdel-Rahman

• Artículos de revistas (11)

• Artículos de revistas

  • Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials

    Omar Mohammed Abdel-Rahman, S. Ghosh, J. Walker

    Clinical & translational oncology, ISSN 1699-048X, Vol. 22, Nº. 9, 2020, págs. 1651-1656

    • Resumen
    

  • Outcomes of clinically localized prostate cancer patients managed with initial monitoring approach versus upfront local treatment: a North American population-based study

    Omar Mohammed Abdel-Rahman

    Clinical & translational oncology, ISSN 1699-048X, Vol. 21, Nº. 12 (December), 2019, págs. 1673-1679

    • Resumen
    

  • Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies

    Omar Mohammed Abdel-Rahman

    Clinical & translational oncology, ISSN 1699-048X, Vol. 21, Nº. 6, 2019, págs. 810-816

    • Resumen
    

  • Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies

    Omar Mohammed Abdel-Rahman

    Clinical & translational oncology, ISSN 1699-048X, Vol. 21, Nº. 4, 2019, págs. 512-518

    • Resumen
    

  • Outcomes of early-stage breast cancer patients treated with sequential anthracyclines–taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial

    Omar Mohammed Abdel-Rahman

    Clinical & translational oncology, ISSN 1699-048X, Vol. 21, Nº. 2 (February), 2019, págs. 239-245

    • Resumen
    

  • Revisiting Dukes’ paradigm; some node positive colon cancer patients have better prognosis than some node negative patients

    Omar Mohammed Abdel-Rahman

    Clinical & translational oncology, ISSN 1699-048X, Vol. 20, Nº. 6 (June 2018), 2018, págs. 794-800

    • Resumen
    

  • Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system

    Omar Mohammed Abdel-Rahman

    Clinical & translational oncology, ISSN 1699-048X, Vol. 20, Nº. 5 (May 2018), 2018, págs. 670-677

    • Resumen
    

  • Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer

    Omar Mohammed Abdel-Rahman

    Clinical & translational oncology, ISSN 1699-048X, Vol. 20, Nº. 4 (April 2018), 2018, págs. 550-556

    • Resumen
    

  • Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer

    Omar Mohammed Abdel-Rahman

    Clinical & translational oncology, ISSN 1699-048X, Vol. 19, Nº. 11 (November 2017), 2017, págs. 1414-1420

    • Resumen
    

  • Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib

    Ángela Lamarca Lete, Omar Mohammed Abdel-Rahman, I. Salu, M. G. McNamara, Juan W. Valle, R. A. Hubner

    Clinical & translational oncology, ISSN 1699-048X, Vol. 19, Nº. 3 (March 2017), 2017, págs. 364-372

    • Resumen
    

  • Doublet BRAF/MEK inhibition versus single-agent BRAF inhibition in the management of BRAF-mutant advanced melanoma, biological rationale and meta-analysis of published data

    Omar Mohammed Abdel-Rahman, H. ElHalawani, H. Ahmed

    Clinical & translational oncology, ISSN 1699-048X, Vol. 18, Nº. 8 (August 2016), 2016, págs. 848-858

    • Resumen
    

Esta página recoge referencias bibliográficas de materiales disponibles en los fondos de las Bibliotecas que participan en Dialnet. En ningún caso se trata de una página que recoja la producción bibliográfica de un autor de manera exhaustiva. Nos gustaría que los datos aparecieran de la manera más correcta posible, de manera que si detecta algún error en la información que facilitamos, puede hacernos llegar su Sugerencia / Errata.